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Since the description of the capillary tube technique by George and Vaughan 
(1)  the  macrophage migration  inhibition  test has  been  widely used  as  an  in 
vitro  correlate  of  delayed  hypersensitivity  and  cellular  immunity  (1-20). 
Migration  inhibition  factor  (MIF),  1 which  is  responsible  for  this  inhibition, 
was found  to  be  released  by sensitized  lymphocytes of  several  species when 
sensitized  cells were  incubated  in  vitro with  antigen.  It has  been repeatedly 
emphasized that the production  of MIF was the  result of a  specific immuno- 
logic reaction  (1-5, 8,  10,  15,  16,  19,  20)  and its detection in vitro reflected a 
state of cellular immunity in vivo (2,  10,  14).  Rarely, a  report suggested that 
MIF might be released by mitogen that was not a specific antigen (21)  or that 
correlation of migration inhibition in vitro and skin test reactions in vivo was 
poor  (22).  Recently,  MIF has  been detected  in  the  medium of  continuously 
growing cell lines, under conditions in which there was presumably no antigenic 
stimulation (23,  24). 
In this paper we present evidence that  MIF is released  by both lymphoid 
and fibroblast cell lines in continuous growth, that its release is dependent upon 
activation of cells to enter the mitotic cycle, and that MIF is associated with 
delayed hypersensitivity and cellular immunity because specific antigen induces 
a  small number of sensitized cells to divide. 
Materials and Methods 
Cell Lines.--Five cell lines were used. Lines WIL2 and 8866 are human diploid lymphocyte 
lines and their biology in culture has been described  (25, 26). YCAB is a  mouse lymphocyte 
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line originating from A  strain mice  (27).  The mouse fibroblast line, 3T3,  derived from Swiss 
mice,  was provided  by  Dr.  M.  Vogt of  the  Salk  Institute and has been maintained by us. 
WI38 is a  diploid fibroblast line that originated from human embryonic lung and was a  gift 
from  Dr.  Fred Jensen of the Wistar Institute.  Repeated  efforts to identify mycoplasma by 
culture,  by  chemical analysis of  microbial  DNA  and  RNA,  and  by  electron  microscopical 
surveillance have been negative.  Control  lymphocytes were enriched to a  98c~  plus  purity 
from normal human peripheral  blood by ]Dr. John Mendelsohn, as described elsewhere (28). 
Culture  Media  and  Conditions.--Cells  were  routinely grown in  Eagle's minimal essential 
medium (MEM)  supplemented with 10% fetal calf serum (FCS) and antibiotics as previously 
described  (26).  The lymphoid lines were seeded at a  concentration of  2  X  105 cells/ml in a 
final volume of  500  ml and  were  incubated  at  37°C  in  stoppered  2-liter  flasks on rotating 
platforms. In approximately 5 days they reached a  concentration of 2-3  X  106 cells/mI. At 
this point cells were arrested in the G~ "stationary phase" of the cell cycle (29). At appropriate 
time intervals after  replacement of media,  supernatants were removed and tested for MIF. 
Fibroblasts were grown at 37°C in l-liter flat bottles containing 50 ml of medium and 5% CO2 
in  air  atmosphere.  Media  were  changed by decantation and  replacement with fresh media. 
In some experiments, as will be specified, cells were grown in the absence of FCS or with 10% 
A  strain mouse serum substituted for FCS. 
Supernatants.--All media and supernatants to be tested for MIF activity were centrifuged 
for 20 min at  1500 rpm, 4°C,  and frozen at  -20°C  until assayed. To eliminate nutritional 
depletion as a  cause of migration inhibition,  samples were dialyzed against  fresh MEM  for 
6-18  hours before  testing.  Material  used for column chromatography was concentrated  ap- 
proximately 20 times by lyophilization and resolution in distilled water.  Approximately 6 ml 
of the concentrated material was applied to a 90 X  2.5  cm G-100 Sephadex column (Pharmacia 
Fine Chemicals Inc., Uppsala, Sweden) and eluted with 0.14 phosphate-buffered saline (PBS). 
Trace quantities of HSAJalI  were added  to  the redissolved  material as a  molecular weight 
marker. The eluted fractions were pooled as shown in Fig. 1, lyophilized, redissolved in 5 ml of 
distilled water,  and  dialyzed against PBS.  0.2-0.4-mi aliquots  of  these fractions were  then 
added to 2.2 ml of media for MIF testing. For control migrations (100%),  unused fresh com- 
plete media (MEM plus FCS) were similarly concentrated and fractionated; to this was added 
0.2--0.4 ml of I'BS. 
MIF Tests.--MIF was assayed, as described by Bloom et al.  (12), with  peritoneal exudate 
cells obtained from normal Hartley guinea pigs 3  4 days after the intraperitoneal injection of 
20  mt  nf  mineral oil.  The cells were  collected  by lavage of the peritoneaI  cavity  with  cold 
Hanks'  balanced  salt  solution,  washed  two  times,  and  resuspended  at  a  concentration  of 
5 X  10  v cells/ml in MEM containing 15()}. normal heat-lnactivated guinea pig serum. The cell 
suspensions, containing 60  70% large mononuclear cells, were put into capillary tubes sealed 
at one end and were centrifuged at 600 rpm for 2  rain. Capillary tubes were cut at the cell- 
medium interface and the sealed ends were fixed with silicone grease to the bottom of a Macka- 
hess chamber. The chambers were filled with test or control media, sealed, and incubated at 
37°C for 20 hr.  After incubation, chambers were photographed,  the negatives projected,  the 
outlines of  the  migration patterns  were  traced  on  bond  paper,  cut  out,  and  weighed.  The 
weight of the cut out pattern was directly proportional  to the area of migration. Each sample 
was tested in at least two chambers so that a  minimum of four migration patterns was ob- 
tained for one sample. The results are expressed as percentage of inhibition: 
mean area of  migration of  experimental (rag) 
Per cent inhil~ition  =  1  .........  X  100. 
mean area of migration of control  (rag) 
Inhibition of 20% or less was not regarded as significant. 
To control and test media, heat-inactivated guinea pig serum was added at a concentration 
of  5~  just before  use.  Controls  comprised:  complete  medium in which cells had  not  been TUBERGEN,  FELDMAN~ POLLOCK, AND  LERNER  257 
grown;  complete medium fractionated and handled in the same  manner  that supernatants 
were handled; supernatants from fresh human peripheral blood lymphocytes that were incu- 
bated for periods of time equal to or greater than the periods during which supernatants of 
continuous  cell lines were collected;  and supernatants of two equal time intervals removed 
from the same flask of cells. In the experiment in which YCAB cells were grown in mouse A 
strain serum and FCS for comparison,  the supernatants were assayed with mouse peritoneal 
exudate cells collected 3 days after intraperitoneal injection of proteose peptone. 
RESULTS 
MIF Production by Continuous Cell Lines.--As  indicated in  Table  I,  in  16 
of 17  trials with the supernatants of four cell lines there was significant inhibi- 
tion.  Controls  consisted of either  complete  fresh  medium  and/or  medium  in 
which  unstimulated  human  peripheral  lymphocytes  had  been  incubated  for 
24-96 hr. No significant differences were seen between the controls. 
TABLE  I 
Production of MIF Activity by Continuous Cell Lines* 
Supernatant of cell  strain  Per cent inhibition 
8866 (Human lymphocyte) 
WIL2 (Human lymphocyte) 
YCAB  (Mouse lymphocyte) 
WI38 (Human fibroblast) 
Normal human lymphocytes 
Media not incubated with cells 
66  51  77 
0  66  69 
67  68  68 
61  69  74 
72 
74  25 
0  0  0 
0  0  0 
* P  <  0.05 for inhibition of 20% or greater. 
Recovery  of MIF Activity from  Sephadex  G-IO0  Chromatography.--Concen- 
trated  supernatants  from  human  (8866)  and  mouse  (YCAB)  lymphoid  lines 
were  eluted from  Sephadex  G-100.  Fig.  1  demonstrates  the  MIF  activity in 
each  pooled  fraction  in  relation  to  the  recovery  of  HSAJ31I  for  the  human 
lymphoid line.  Significant inhibition was  seen  in  those  fractions  eluting with 
and behind albumin,  comparable to the elution behavior of MIF  described by 
Remold  et  al.  (30).  Fig.  2  presents  similar data  for  mouse  lymphoid  MIF, 
namely that MIF  begins to elute in the fraction containing albumin although 
the greatest amount of activity occurs in the fraction eluting behind albumin. 
In  terms  of estimated  molecular size,  30,000-55,000,  MIF  produced by  con- 
tinuous  human  and mouse  cell lines corresponded to  that  described for  MIF 
produced by sensitized ceils incubated with antigen (30-32). 
MIF Release  Related to Phase of the Cell Cyde.--A  synchronized culture of 
8866  cells was initiated with greater than 95 %  of the cells in the  GI phase of 
the cell cycle. DNA synthesis, as measured by the uptake of thymidine-t4C, began 
at about 8 hr after synchronization, peaked at 20 hr, and then rapidly declined. 258  MACROPIfAGE MIGRATION INHIBITION FACTOR 
Fig. 3 demonstrates the amount of inhibition found with supernatants from Gz 
(0-8  hr),  early  S  (8-12  hr),  and  late  S  (12-24  hr)  phases  in  such  cuItures. 
Significant  inhibition  was  present  in  the  late  S  phase  of  the  cell  cycle.  No 
MIF was detected in supernatants  of G1 and early S phases. This experiment 
was repeated three times and yielded similar results each time. 
Supernatants of the different phases were concentrated and tested at varying 
dilutions  to  measure  semiquantitatively  the  amount  of  MIF  released  during 
each phase of the cell cycle. Fig. 4 illustrates that the  12-24-hr S phase super- 
natant,  spanning a 50% greater time interval than the 0-8-hr G~ supernatant, 
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Fio. 1.  Recovery of MIF produced by human lymphoid cells (8866) from Sephadex G-100. 
The column eluates were pooled into fractions as indicated by the roman numerals. Vertical 
bars represent per cent inhibition; vertical lines indicate -4-SE. Continuous solid line constructed 
from counts per minute of radioactivity. 
contained  four  times more MIF activity than  was detectable in  G1 material. 
There was, however, some inhibition with the eight times concentrated samples 
of both 0-8-  and 8-12-hr periods.  This was most likely related to incomplete 
synchrony and  did not detract  from the  observed relationship between DNA 
synthesis and MIF release. 
MIF  Prod~ction  by  Grow#~g and  Contac! !nhibiled  F~broblasts.--Previous 
reports have documented the loss of mitotic activity by and synchrony in  G1 
of 3T3  fibroblasts during  contact  inhibition  (33-35).  Therefore we compared 
the  amount of inhibition  produced by supernatants  of 3T3 fibroblasts during 
the  growth phase of cultures  with  those contact-inhibited  cells collected over 
a similar length of time, as shown in Table II. The greatest inhibition occurred 
with  supernatants  of  growing  fibroblasts.  There  was  also  MIF  activity  in 
supernatants of contact-inhibited  cells,  but it was substantially less than that TUBERGEN, FELDMAN, POLLOCK, AND  LERNER  259 
in  supernatants  of  growing  cells.  The  presence  of  MIF  in  supernatants  of 
contact-inhibited fibroblasts may be  related  to  the  observation that  merely 
adding fresh serum, as was done in this experiment, triggers a small proportion 
of the G1 cells to enter the mitotic cycle, divide, and again stop in G1 (35, 36). 
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FzG. 2.  Recovery of MIF produced by mouse lymphoid cells (YCAB) from Sephadex 
G-100. The column eluates were pooled into fractions as indicated by the roman numerals. 
Vertical bars represent per cent inhibition;  vertical lines indicate ±sE. Continuous solid line 
constructed from counts per minute of radioactivity. 
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Fto. 3.  Production  of MIF by synchronized lymphocytes  (8866) in relatianship  to the 
thymidine-14C uptake.  Three  time periods 0-8 (G~), 8-12  (early S), and 12-24 hr  (late S) 
are shown. Per cent inhibition  is indicated by the vertical bars; vertical lines represent ~sE. 260  MACROPHAGE  MIGRATION  INHIBITION  FACTOR 
MIF Production  by Mouse Lymphocytes  in Homologous  Serum.--The  possi- 
bility  existed  that  lymphocytes  in  media  containing  FCS  released  MIF  in 
response  to  an  antigenic  stimulation  provided  by  FCS.  This  possibility  was 
examined by growing thoroughly washed YCAB cells in parallel,  in  10%  FCS 
and  10%  A  strain  mouse  serum.  After 4  days  the  cells  were  sedimented  and 
the supernatants tested for MIF activity against mouse peritoneal exudate cells. 
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FIG. 4.  MIF activity in concentrated supernatants  from synchronized lymphocytes (8866). 
Vertical  bars  depict  per  cent inhibition;  vertical  lines represent  4-sE. Open bars,  control 
normal medium; hatched  bars, 0-8-hr collection (G~); dotted bars, 8-12-hr  collection (early 
S phase) ; solid bars, 12-24-hr collection (late S phase). 
TABLE II 
Production of MIF by Growing and Contact-Inhibited Fibroblasts 
Supernatant 
Per cent inhibition  (4-  se) 
Exp.  1  Exp.  2  Exp.  3 
Control media  0 (4- 5.1)  0 (4- 5.2)  0 (4- 4.8) 
Contact inhibited  6.6 (4- 4.7)  59.2  (4- 3.8)  13.5  (4- 8.0) 
Growth phase  56.4 (4- 6.9)  81.4 (4- 4.2)  74.4 (4- 8.2) 
As  shown  in  Table  III  both  supernatants  contained  significant  amounts  of 
MIF activity. 
MIF  Production  by  Human  Lymphoid  Cells  in  Serum-Free  Media.--If 
purification  of MIF is  to be accomplished  by the use of continuous cell lines, 
it  is  desirable  to  have  as  little  extraneous  protein  as  possible  in  the  starting 
material.  Also,  a  protein-free  medium  would  eliminate  any  possibility  of 
antigenic  stimulation.  Lymphoid  cells  (line  WIL2)  were  planted  at  2  X  l0  p 
cells/ml in media containing FCS. When the cell  concentration reached 9.0 X 
l0  p cells/ml,  the  cells  were  washed  with  MEM  and  resuspended  at  the  same 
concentration in either MEM with 10% FCS or in MEM without added serum. 
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serum and 14.1  X  10~/ml in the culture free of serum. The supernatants were 
tested for MIF activity after adding FCS to the protein-free supernatant  and 
as shown in Table IV the production of MIF was essentially the same in both 
supernatants.  The above experiment was repeated  with 8866 cells and yielded 
similar results. 
TABLE III 
Production  of MIF by  24-Hr  Cultures  of Mouse  Lymphoid  Cells in Isologous  Mouse  Serum 
and Fetal Calf Serum 
Supernatant  Per cent inhibition (-k  SE) 
Fresh media with 10% mouse serum  0 (4- 9.0) 
Supernatant  with 10% fetal calf serum  85 (4- 3.9) 
Supernatant with 10% isologous serum  93 (4- 1.6) 
Each figure represents  the mean of four measurements. 
TABLE IV 
Production  of MIF by 24-Hr  Cultures  of Human Lymphoid  Cells in Serum-Free  Media  and 
Media  Containing  10% Fetal Calf Serum 
Supernatant  Per cent inhibition (~ sE) 
Fresh media with 10% fetal calf serum  0 (4- 13.0) 
Supernatant with 10% fetal calf serum  68 (4- 7.4) 
Supernatant with  10% fetal calf serum added  after  cell incubation  75 (4- 3.3) 
in protein-free media 
Each figure represents the mean of four measurements. 
DISCUSSION 
The evidence presented here indicated that MIF release was associated  with 
activation of cells from a resting state into the mitotic cycle, particularly  with 
S-phase  cells.  Resting  lymphocytes,  almost  100%  purified  from  peripheral 
blood of normal human donors and ahnost all in Go, did not release  MIF into 
media  throughout  cultivation  periods  of  24-96  hr.  By  contrast,  MIF  was 
readily  and  reproducibly  assayed  in  media  of  continuously  proliferating 
lymphocyte lines, both human and murine. Furthermore,  when synchrony was 
established in one human cell line, i.e. about 95 %  of the cells in culture were in 
Gt  and  then  permitted  to  grow,  MIF  was  detected  only  in  S  phase.  These 
results  were consistent  with  the  observation  of Bennett  and  Bloom (37)  that 
after  antigen  was  added  to  sensitized  lymphocytes a  period  of 6  hr  elapsed 
before  MIF  could  be  assayed,  and  also  with  the  observations  that  certain 
metabolic inhibitors,  notably actinomycin D  and puromycin, prevented release 
of MIF  (38). These reagents may have stopped cells from entering S phase of 262  MACROPHAGE  MIGRATION  INIIIBITION  FACTOR 
the cell cycle. It should be emphasized that actual cell division was not required 
to release MIF. 
The results of the experiments with 3T3 fibroblasts corroborated those ob- 
tained with  the  lymphocyte lines.  Actively growing fibroblasts in  culture re- 
leased significantly greater quantities of MIF  than did  the same  cells  during 
periods of contact inhibition. These results appeared even more striking when 
we calculated that during growth phase  of 4  days needed to reach a  state  of 
contact inhibition the average number of cells in culture was about 25 % of the 
number of cells  present during contact inhibition.  Thus a  smaller number of 
proliferating cells produced a  greater quantity of MIF than did four times as 
many  cells  in  a  state  of  contact  inhibition  (G,),  a  state  that  is  somewhat 
analogous to Go (26,  29).  Some MIF was assayed in supernatants  of contact- 
inhibited cells and this was attributed to the fact that addition of fresh medium 
to an inhibited culture activated a small proportion of GI cells  to enter S  (35, 
36). 
The  association  of  MIF  release  with  cycling  cells  provoked  a  number  of 
important questions. First, was the MIF of continuously growing cell lines the 
same as or similar to MIF generated by the interaction of sensitized lympho- 
cytes and  specific antigen?  Since MIF has  not been chemically nor immuno- 
logically identified, one can only compare the few biophysical features of MIF 
from different sources.  MIF  released by  continuously proliferating cell  lines 
was  eluted  from  Sephadex  (}-100  in  the  same  manner  and  under  the  same 
conditions  as  MIF  generated  by  the  interaction  of  antigen  with  sensitized 
lymphocytes (30-32). This finding was suggestive of similarity between MIF 
from human,  murine,  and  guinea pig cells,  produced under different circum- 
stances, but was in no way proof of identity nor did it certify the singularity 
of MIF, i.e., there may be several such factors. Indeed the assay for MIF is a 
nonspecific test that measures inhibition of macrophage migration  and  there 
are  certainly  many  reagents,  without  immunologic  specificity,  that  might 
accomplish  this  (39-41).  Further,  Amos  and  Lachmann  described  an  MIF 
that  was  antigen  dependent;  it  inhibited  macrophage migration  only in  the 
presence of antigen (15). 
A  second question provoked by the  results of this  report was  what  is  the 
relationship of MIF to other lymphokines that are generated by activated cells 
(23, 32, 39, 40, 42) e.g., lymphotoxin, chemotactic factors, agglutinating agents, 
etc.  Nonspecific stimulants  of cell  proliferation such  as  concanavalin A  and 
phytohemagglutinin  have  been  reported  to  release  skin  reactive  factor  (40) 
and  lymphotoxin  (39),  respectively. Furthermore,  continuously growing  cell 
lines, that replicate in the absence of known stimulants, produce lymphotoxin 
and  MIF  (23)  and  our line  8866  makes  interferon  (S.  H.  Baron,  personal 
communication).  Until  one  or  more  of  these  factors  has  been  isolated  and 
identified it will not be possible to establish a relationship, if any, among them. 
A third important question was what is the relationship of MIF to delayed TUBERGEN,  FELDMAN, POLLOCK, AND  LERNER  263 
hypersensitivity and cellular immunity. Originally, MIF was found in medium 
after incubation of sensitized lymphocytes with specific antigen and was pre- 
sumed  to  be  an  in  vitro  correlate of  delayed hypersensitivity. Our  studies 
indicated that MIF was a product of mitotic activity or of cells preparing to 
divide, and many stimuli, immunologic or nonimmunologic, that would activate 
ceils to enter S phase would suffice to cause release of MIF.  Several of our 
experiments  were  designed  to  rule  out  the  possibility  that  proliferation  of 
continuously growing cell lines was a response to antigens by cells cloned for 
these antigens.  First,  it would  be highly unlikely that fibroblasts divided in 
response to antigens and thus produced MIF as an immunologic product. More 
telling arguments rested on the fact that MIF was released by cells grown in 
homologous serum  in  the  absence  of FCS,  a  medium  that  did  not  contain 
antigenic substances,  and also on the fact that MIF was released by cells in 
medium lacking any protein. That mycoplasma or other bacterial contaminants 
played no role was confirmed by our inability to identify them on numerous 
occasions by culture and electron microscopical surveillance. 
MIF released by the interaction of sensitized cells and specific antigen would 
then reflect a  restricted situation in which  a  small number of the  cells were 
stimulated by antigen to divide. In circumstances in which most of the proliferat- 
ing cells were activated by antigen, the release of MIFmight be regarded as  a 
product of an immunologic reaction, but when cells  stimulated to divide  by 
antigen represented only a fraction of all dividing cells,  then MIF could not be 
considered an immunologic reagent. 
SUM2~ARY 
Macrophage  migration  inhibitory  factor  (MIF)  was  found  in  media  of 
human and mouse lymphocyte and fibroblast cell lines that were continuously 
growing.  Its  release  was  dependent  on  activation  of  the  cells  to  enter  the 
mitotic cycle, particularly on cells in S phase. The greatest quantity of MIF 
was detected in supernatants of lymphocytes collected during S phase after the 
cells were synchronized in G1 and in supernatants of growing fibroblasts. When 
the latter were contact inhibited little or no MIF was found in media.  MIF 
was also released into media of cells proliferating in homologous serum in the 
absence  of fetal  calf serum  and  into  media  lacking  any  protein.  The  MIF 
produced by lymphocyte lines eluted from Sephadex G-100 in the same fashion 
as MIF produced by the interaction of sensitized guinea pig cells and antigen. 
The results indicated  that MIF is not a  specific mediator of delayed hyper- 
sensitivity and cellular immunity and that MIF released by sensitized lympho- 
cytes incubated with antigen merely reflects that fraction of cells activated by 
antigen to enter the mitotic cycle, 
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